Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Karen L. Sundell
Based on 16 articles published since 2010
(Why 16 articles?)
||||
Expertise Level
The expertise of Karen L. Sundell ranks in the
  • Top 1.6%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 16 articles on the topic.
Graphical view (beta)
Aliases Sundell, Karen   ·   Sundell, K   ·   Sundell, Karen L
Work Locations
Details
Most likely:    Eli Lilly Corporation      
2019
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Erl Wood Manor, Surrey, UK. · Bioclinica, Newark, CA, USA. · Bioclinica, Lyon, France. · Avid Radiopharmaceuticals, Philadelphia, PA, USA. · Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Neurology Associates, Boston, MA, USA. · Pubmed 31388559
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Windlesham, UK. · Siemers Integration, LLC, Zionsville, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 30511011
2017
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Avid Radiopharmaceuticals, Philadelphia, PA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · inVentiv Health, Inc., Burlington, MA, USA. · Molecular NeuroImaging, New Haven, CT, USA. · Pubmed 28365320
2016
  • Department Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · BioClinica, CA, USA. · Department Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA, USA. · Pubmed 27109039
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · Avid Radiopharmaceuticals, Philadelphia PA, USA. · Pubmed 26238576
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Pubmed 29067306
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Pubmed 27239541
2015
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 26402769
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 25125457
  • Eli Lilly and Company, Indianapolis, IN, USA. · Department of Neurology, Columbia University Medical Center, New York, NY, USA. · Departments of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Centre des Maladies Cognitives et Comportementales (IM2A), Institut du Cerveau et de la Moelle épinière (ICM), UMR-S975, Université Pierre et Marie Curie- Paris6, AP-HP, Hôpital de la Salpêtrière, Paris, France. · RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, UK. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA. · University of Southern California, CA, USA. · Pubmed 27019841
  • Lilly Research Laboratories, Indianapolis, IN, USA. Electronic address: · Lilly Research Laboratories, Indianapolis, IN, USA. · Department of Psychiatry and the Behavioral Sciences and Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. · Pubmed 24613705
2018
  • Hong Liu-Seifert, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, Email: , Phone: +1 317-433-0662. · Pubmed 29972211
2014
2012
Probable:    Indiana University Indianapolis   Contact    
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 16 total) written by Karen L. Sundell about Alzheimer Disease:

  • Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease. 2019
  • Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. 2018
  • Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia. 2018
  • Analysis of the Relationship of Cognitive Impairment and Functional Impairment in Mild Alzheimer's Disease in EXPEDITION 3. 2018
  • Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials. 2017
  • Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort. 2016
  • Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. 2016
  • Quantile regression to characterize solanezumab effects in Alzheimer's disease trials. 2016
  • Function and clinical meaningfulness of treatments for mild Alzheimer's disease. 2016
  • Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease. 2015
Show List of Full Article Records
Google Searches

Learn more about Karen L. Sundell using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Eli Lilly Corporation
Indiana University Indianapolis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Eli Lilly Corporation
2019
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Erl Wood Manor, Surrey, UK. · Bioclinica, Newark, CA, USA. · Bioclinica, Lyon, France. · Avid Radiopharmaceuticals, Philadelphia, PA, USA. · Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Neurology Associates, Boston, MA, USA. · Pubmed 31388559
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Windlesham, UK. · Siemers Integration, LLC, Zionsville, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 30511011
2017
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Avid Radiopharmaceuticals, Philadelphia, PA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · inVentiv Health, Inc., Burlington, MA, USA. · Molecular NeuroImaging, New Haven, CT, USA. · Pubmed 28365320
2016
  • Department Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · BioClinica, CA, USA. · Department Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, CA, USA. · Pubmed 27109039
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · Avid Radiopharmaceuticals, Philadelphia PA, USA. · Pubmed 26238576
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Pubmed 29067306
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Pubmed 27239541
2015
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 26402769
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 25125457
  • Eli Lilly and Company, Indianapolis, IN, USA. · Department of Neurology, Columbia University Medical Center, New York, NY, USA. · Departments of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Centre des Maladies Cognitives et Comportementales (IM2A), Institut du Cerveau et de la Moelle épinière (ICM), UMR-S975, Université Pierre et Marie Curie- Paris6, AP-HP, Hôpital de la Salpêtrière, Paris, France. · RICE (The Research Institute for the Care of Older People), Royal United Hospital, Bath, UK. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA. · University of Southern California, CA, USA. · Pubmed 27019841
  • Lilly Research Laboratories, Indianapolis, IN, USA. Electronic address: · Lilly Research Laboratories, Indianapolis, IN, USA. · Department of Psychiatry and the Behavioral Sciences and Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. · Pubmed 24613705
2018
  • Hong Liu-Seifert, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, Email: , Phone: +1 317-433-0662. · Pubmed 29972211
2014
2012
Indiana University Indianapolis
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
Yearly article counts 01314420100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.